Trauma surgeons’ role in gun violence prevention is hampered by restrictions on funding for research with implications for public health interventions.
AMA J Ethics. 2018;20(5):475-482. doi:
10.1001/journalofethics.2018.20.5.msoc1-1805.
Public health surveillance for infectious disease provides a model for a mandatory reporting policy for human trafficking, which poses risks for survivors.
AMA J Ethics. 2017;19(1):45-53. doi:
10.1001/journalofethics.2017.19.1.stas1-1701.
Implementation of child abuse reporting laws may help policymakers assess the potential risks and benefits of mandatory reporting of human trafficking.
AMA J Ethics. 2017;19(1):54-62. doi:
10.1001/journalofethics.2017.19.1.pfor1-1701.
In an extreme response to the threat of student violence, a school district in Texas certified its teachers to carry weapons and sanctioned them to respond to threats with deadly force if necessary.
As the United States became more successful in preventing and treating many infectious diseases, homicide and suicide rose in the rankings of causes of death.
The greatest pressure to resuscitate the extremely low-birth-weight infant often results from successful marketing efforts that lead families to expect that their premature infants will be cute and healthy.
Physicians new to a case might object to an established care plan. Practice variation, clinical momentum, and how value is assigned by different parties to acute care and comfort measures can each contribute to conflict in these cases.
AMA J Ethics. 2018;20(8):E699-707. doi:
10.1001/amajethics.2018.699.
Kyle B. Brothers, MD, PhD and Esther E. Knapp, MD, MBE
Direct-to-consumer genetic testing requires that physicians share decision making with patients, not order unnecessary tests or interventions, and refer to genetic specialists when necessary.
AMA J Ethics. 2018;20(9):E812-818. doi:
10.1001/amajethics.2018.812.
Mandatory genetic testing of health care professionals could help structure health care organizations’ responses to a pandemic. Patients and more susceptible employees can benefit, and these benefits must be weighed against concerns about fairness, autonomy, genetic privacy, and potential loss of employment opportunities.
AMA J Ethics. 2018;20(9):E819-825. doi:
10.1001/amajethics.2018.819.
Clara C. Hildebrandt, MD and Jonathan M. Marron, MD, MPH
Gene editing with CRISPR/Cas9 raises concerns about equitable access to therapies that could limit research participation by minority group members. These concerns can be addressed through public education, transparency, and stakeholder partnerships.
AMA J Ethics. 2018;20(9):E826-833. doi:
10.1001/amajethics.2018.826.